Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.

被引：0
|
作者：
Ma, K. [1 ]
Sun, C. [1 ]
Jia, X. [1 ]
Wang, X. [1 ]
Xu, Y. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
Shao, G. [1 ]
Zhang, P. [1 ]
Liu, Y. [1 ]
Ma, X. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
non-small cell lung cancer; Immunotherapy; neoaduvant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P79.09
引用
收藏
页码：S649 / S650
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
  • [2] Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
    Ferrer, Loic
    Nadal, Ernest
    Guidel, Floriane
    Insa, Amelia
    Menu, Philippe
    Casal, Joaquin
    Domine, Manuel
    Massuti, Bartomeu
    Majem, Margarita
    Martinez-Marti, Alex
    Garcia Campelo, Rosario
    de Castro Carpeno, Javier
    Cobo, Manuel
    Vivanco, Guillermo Lopez
    del Barco, Edel
    Bernabe, Reyes
    Vinolas, Nuria
    Barneto, Isidoro
    Colin, Thierry
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [4] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
  • [5] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [6] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Y.
    Yan, B.
    You, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S108 - S109
  • [8] Treatment of resectable stage IIIA non-small cell lung cancer
    Cardenal, Felipe
    Palmero, Ramon
    JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : 13 - 15
  • [9] Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patients
    Tao, Xiaoting
    Yuan, Chongze
    Zheng, Difan
    Ye, Ting
    Pan, Yunjian
    Zhang, Yawei
    Xiang, Jiaqing
    Hu, Hong
    Chen, Haiquan
    Sun, Yihua
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1443 - 1455
  • [10] Is the combination of neoadjuvant and adjuvant chemotherapy in marginally resectable IIIA non small cell lung cancer (NSCLC) feasible?
    Kolek, Vitezslav
    Grygarkova, I.
    Cwiertka, K.
    Hajduch, M.
    Klein, J.
    Neoral, C.
    ANNALS OF ONCOLOGY, 2006, 17 : 223 - 224
12345